JPH04243834A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
JPH04243834A
JPH04243834A JP3012849A JP1284991A JPH04243834A JP H04243834 A JPH04243834 A JP H04243834A JP 3012849 A JP3012849 A JP 3012849A JP 1284991 A JP1284991 A JP 1284991A JP H04243834 A JPH04243834 A JP H04243834A
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutical composition
dry
day
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3012849A
Other languages
Japanese (ja)
Other versions
JPH0761953B2 (en
Inventor
Shintoku Rin
リンシントク
Youki Rin
リンヨウキ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Musashino Research Institute for Immunity Co Ltd
Original Assignee
Musashino Research Institute for Immunity Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Musashino Research Institute for Immunity Co Ltd filed Critical Musashino Research Institute for Immunity Co Ltd
Priority to JP3012849A priority Critical patent/JPH0761953B2/en
Publication of JPH04243834A publication Critical patent/JPH04243834A/en
Publication of JPH0761953B2 publication Critical patent/JPH0761953B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE: To obtain a medicinal composition effective to a cancer, especially a leukemia, a polyp (stomach, intenstine, vocal cord, gallbladder and bile duct), a uterus cancer, an ovary cancer, a breast cancer, a urinary bladder cancer, a pancreas cancer, a hysteromyoma, a lung cancer, a rheumatoid arthritis, a neuralgia and arthritis, alleviating the symptoms of AIDS, a collagen disease, a Raynaud's syndrome, a hepatitis, a renal failure, dysfunctions of kidney, spleen pancreas and intestine, and obesity, and capable of being used effectively and safely in the body status improvement in a dermatitis, an atopic trait, an allergic trait, when removing hairs, etc., and also administered before the discharge of ascites or before the renal dialysis for the acceleration of recovery. CONSTITUTION: This agent is obtained by adding an extract of the seeds of Phyllostachys pubescans to Hoelen, maturing and drying, also adding extracts of Arecae seemen, Rhei rhizoma, Drinaria fortunel, etc., to Talcum crystalinum, mixing and drying, and adding a crushed raw Bidens pilosal var. minor and bezoar bovis dissolved in hot water consecutively and repeatedly for absorbing into the above dried powders to make a whole material as a uniform dried powder.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は癌特に白血病・ポリ−プ
(胃・腸・声帯・胆嚢・胆管)・子宮癌・卵巣癌・乳癌
・膀胱癌・膵臓癌・子宮筋腫・肺癌、リュウマチ・神経
痛・関節炎に有効で、エイズ、膠原病・レイノ−症状、
肝炎、腎不全、腎・脾・膵・腸機能低下、肥満などの症
状軽減、その他皮膚炎・アトピ−性体質・アレルギ−体
質や脱毛時の体質改善などに有効且つ安全に使用できる
医薬品組成物を提供しようとするものであり、又腹水を
抜く前や腎透析の前に投与することにより回復を早める
ために使用するものである。
[Field of Industrial Application] The present invention is applicable to cancer, particularly leukemia, polyps (stomach, intestines, vocal cords, gallbladder, bile ducts), uterine cancer, ovarian cancer, breast cancer, bladder cancer, pancreatic cancer, uterine fibroids, lung cancer, rheumatism, Effective for neuralgia, arthritis, AIDS, collagen disease, Raynaud's symptoms,
A pharmaceutical composition that can be used effectively and safely for alleviating symptoms such as hepatitis, renal failure, decreased kidney, spleen, pancreatic, and intestinal function, and obesity, as well as for improving the constitution of dermatitis, atopic constitution, allergic constitution, and hair loss. It is also used to speed up recovery by administering it before draining ascites or before renal dialysis.

【0002】0002

【従来の技術】癌に対する漢方生薬製剤の使い方として
は手術の後療法として十全大補湯や補中益気湯等で全身
状態の改善を計り、或は手術のできない場合でも免疫力
の向上を期待して十全大補湯等が使用され、又小柴胡湯
や人参湯の有効なことも知られており、これらが5−フ
ルオロウラシル等の抗癌剤と併用されることもしばしば
である。
[Prior art] The use of Chinese herbal medicine preparations for cancer is as post-surgery treatment to improve the general condition with Juzentaihoto or Hochuekkito, or to improve immunity even in cases where surgery is not possible. Juzentaihoto and the like are used in anticipation of this, and Shosaikoto and Ninjinto are also known to be effective, and these are often used in combination with anticancer agents such as 5-fluorouracil.

【0003】又膠原病ではしばしば長期にわたってステ
ロイド剤が使用され、その副作用として潰瘍や腎臓障害
をもたらし投薬が続けられなくなることが多いが、この
ような場合桂芍知母湯、桂枝加求附湯、桂枝二越婢一湯
、真武湯、十全大補湯或は麦門冬湯が使用され、アレル
ギ−疾患・アトピ−性疾患ではその症状に応じて小青龍
湯、麻杏甘石湯、柴朴湯、神秘湯、麦門冬湯、五虎湯等
のほかに大防風湯も有効とされている。
[0003] Also, steroids are often used for long periods of time in collagen disease, resulting in side effects such as ulcers and kidney damage, making it impossible to continue taking the medication. , Keishi Futakoshi Kyoichito, Shinbuto, Juzentaihoto or Bakumondoto are used, and for allergic diseases and atopic diseases, Shoseiryuto and Masan Kansekito are used depending on the symptoms. , Saiboku-yu, Mystic-yu, Bakumon-fu-yu, Goko-yu, and Daibofu-yu are also said to be effective.

【0004】然し乍ら上記手段は有効例はあっても効果
が充分でなく、病巣の活動を抑制し、更に萎縮した組織
の再生、活性化をもたらすほどの作用はなく、多くの場
合病状の進行を遅くする程度の作用にすぎない。
However, although the above-mentioned measures are effective in some cases, they are not sufficiently effective, and do not have sufficient effects to suppress the activity of lesions or regenerate or activate atrophied tissues, and in many cases, they do not have the effect of suppressing the activity of lesions or regenerating or activating atrophied tissues. It's just a slowing effect.

【0005】[0005]

【発明が解決しようとする課題】医薬品の副作用は元来
人間にとって異物である化合物を人体に投与することに
よって人体がこれに抵抗し、防衛作用を発揮するために
起こるものである、そもそも生体が経験したことのない
異物の作用というものは、これに人体がどのように反応
を示すか予測し難いものであって、薬物の作用は主作用
も、副作用もあり、その時の生体の状況によって何れが
主作用か副作用かというわけでもなく、人体にとって都
合の良いものが主作用、都合の悪いものが副作用という
ことになる、その上動物殊に人には個体差というものが
あって、統計的に処理できるほどの試験例を重ねたとし
ても、尚特異な反応を起こす個体がないとは言い難く、
薬物が合成医薬品である場合は殊にその問題が大きい。
[Problem to be solved by the invention] Side effects of pharmaceuticals occur because the human body resists and exerts a defensive action when a compound that is originally foreign to humans is administered to the human body. It is difficult to predict how the human body will react to the effects of a foreign substance that has never been experienced before, and drugs have both main effects and side effects, and they vary depending on the biological situation at the time. It does not necessarily mean that the effect is the main effect or the side effect; what is convenient for the human body is the main effect, and what is not convenient for the human body is the side effect.Furthermore, there are individual differences among animals, especially humans, and statistical Even if a large number of test cases were conducted, it would still be difficult to say that there were no individuals who had a unique reaction.
This problem is especially serious when the drug is a synthetic drug.

【0006】本発明は地球上の動物は云うまでもなく人
類が有史以来、自然にその生命を維持するのに利用して
きた身近な各種植物や動物性食品の廃物を利用し、中に
は既に生薬としての地位を確立しているものもあるが、
これらを原料として古来伝承された処方を基本とし、経
験に基づく独特の加工法により効果の発現を確実にし、
更にこれに改良を加え、極めて安全性が高く、且つ患者
にとって不利な副作用が殆どみられない上に効果の確実
な原料配合及びその加工方法を確立したものである。
[0006] The present invention utilizes the waste products of various familiar plants and animal foods that humans, not to mention animals on earth, have used to sustain their lives naturally since the beginning of recorded history. Although some have established their status as crude drugs,
Based on recipes handed down from ancient times using these ingredients as raw materials, we use unique processing methods based on experience to ensure the expression of effects,
By further improving this, we have established a combination of raw materials and a processing method that is extremely safe, has virtually no adverse side effects for patients, and is highly effective.

【0007】[0007]

【課題を解決するための手段】本発明は二千年来時代と
共に改良されつつ発明者の家に脈々として伝えられてき
た処方に、発明者がその使用経験と絶え間ない研究に基
づき更に改良を加えてきたもので、実証虚証に関係なく
かなり広い範囲の適応症に対し、投薬量のみを加減する
ことにより西洋医学療法で改善の見られない患者に就い
ても著効を奏することが多く、その効果の的確性と広範
なことは類を見ないものである。
[Means for Solving the Problems] The present invention is based on the inventor's experience of using the recipe and continuous research on the recipe that has been passed down to the inventor's family over the past 2000 years and has been improved over time. Regardless of proven or false evidence, it is often effective for a wide range of indications, even in patients who have not seen improvement with Western medical therapy, by simply adjusting the dosage. , the precision and breadth of its effects are unprecedented.

【0008】本発明において使用する原料は次のとおり
である、■茯苓:Hoelen.サルノコシカケ科の担
子菌類の一種であるマツホド(Poria  coco
s  Wolf)の外層を殆ど除いた菌核で、生薬とし
て取引されるものは干したもので日局11にも収載、利
尿・健胃・鎮静作用があるとされている。
[0008] The raw materials used in the present invention are as follows: ■ Hoelen. Poria coco, a type of basidiomycete in the family Arunochidae.
The sclerotia from which most of the outer layer has been removed (S. Wolf) is dried and is traded as a herbal medicine.It is listed in the Japanese Bureau of Pharmacy No. 11 and is said to have diuretic, stomachic, and sedative effects.

【0009】■毛筍:茅竹筍とも云う、モウソウチクP
hyllostachys  pubescens  
MAZEL  EX  H.de  lehaieの苗
、猫頭竹・江南竹・狸頭竹その他の異名があり、その成
分として水分88%の可食部100g中に鉄0.5mg
、カルシュウム10mg等の他、マウスのエ−ルリッヒ
癌とサルコ−マ180に抵抗する作用を持つ多糖類の存
在が報告されており、古来解毒の目的で用いられている
〔中薬大辞典−小学館〕。
[0009] ■ Hairy bamboo shoots: Also called hairy bamboo shoots, Moso bamboo shoots P.
hyllostachys pubescens
MAZEL EX H. de lehaie seedlings, also known as cat head bamboo, Jiangnan bamboo, raccoon head bamboo, and other names, and its ingredients include 0.5 mg of iron in 100 g of edible portion with 88% water content.
In addition to 10 mg of calcium, the existence of polysaccharides that have the effect of resisting Ehrlich's carcinoma and Sarcoma 180 in mice has been reported, and has been used for detoxification since ancient times [Dictionary of Chinese Medicine - Shogakukan ].

【0010】■檳榔子:ビンロウジAreca  ca
techu  Linneの種子、生薬として取引され
るものは通常果肉から分離した種子を石灰水又は水と煮
沸後乾燥したもので、果実のまま火力乾燥してから種子
を分離したものもあり、日局11にビンロウジ(ARE
CAE  SEMEN)として収載、条虫駆除作用・止
瀉作用があるものとされるが、本発明では成熟した新鮮
なものを天日乾燥して使用する。
■Betel nut: Areca ca
Techu Linne seeds, which are traded as crude drugs, are usually the seeds separated from the pulp, boiled with lime water or water, and then dried, and there are also those whose seeds are separated after drying the fruit with heat. Areca nut (ARE)
It is listed as CAE SEMEN) and is said to have tapeworm exterminating and antidiarrheal effects, but in the present invention, it is used freshly matured and dried in the sun.

【0011】■滑石:神農本草経以来の利水の要薬で含
水珪酸アルミニュウム・含水珪酸マグネシュウム・含水
珪酸カルシュウムマグネシュウム等であり、灰白色、ク
リ−ム色、時には赤褐色を帯びたものもあり、鉄を含む
ものもあるが、塊状・繊維状など細かい結晶の集合体又
は板状又は鱗状の結晶として産し、古来消炎・利尿・止
瀉・切傷・等に用いられ、日本薬局方外生薬規格にカッ
セキ(TALCUMCRYSTALLINUM)として
収載されているものは天然の含水珪酸アルミニュウム及
び二酸化珪素などからなり、日局11にタルク(TAL
CUM)として収載されているものは天然の含水珪酸マ
グネシュウムで、時に少量の珪酸アルミニュウムを含む
とされているが、本発明で使用するものはどのようなも
のでも良い。
[0011] Talc: An important water use medicine since the Shen-Nung Bent Herbal Classics, it contains hydrated aluminum silicate, hydrated magnesium silicate, hydrated calcium silicate, and magnesium. It is produced as aggregates of fine crystals such as lumps and fibers, or plate-like or scale-like crystals, and has been used for anti-inflammatory, diuretic, antidiarrheal, cutting, etc. since ancient times, and is listed in the Japanese Pharmacopoeia Non-Herbal Medicine Standards. The substance listed as TALCUMCRYSTALLINUM is made of natural hydrous aluminum silicate and silicon dioxide, and is listed as talc (TALC) in Japanese Bureau 11.
What is listed as CUM is a natural hydrous magnesium silicate and is said to sometimes contain a small amount of aluminum silicate, but any material may be used in the present invention.

【0012】■大黄:Rhei  Rhizoma,R
hubarb.たで科植物の薬用大黄(Rheum  
officinale  Baill)、唐古特大黄(
Rheumtanguticum  Maxim.ex
  Balf).掌葉大黄(Rheum  palma
tum  L.)等の根茎であり、生薬として取引され
るものは通常陰干しで風乾したもので日局11にも収載
され、止瀉・健胃・利尿・整腸等に用いられる。
■Rhei Rhizoma, R
hubarb. Medicinal rhubarb (Rheum), a plant of the Octopus family.
official Baill), Tango special rhubarb (
Rheumtanguticum Maxim. ex
Balf). Rheum palma
tum L. ) and other rhizomes, which are traded as herbal medicines are usually dried in the shade and air-dried, and are listed in Japanese Pharmacopoeia No. 11, and are used for anti-diarrhea, stomach health, diuresis, intestinal regulation, etc.

【0013】■牛黄:Bezoar  Bovis,O
riental  Bezoar.ウシ科の動物、黄牛
(ウシ)・水牛の胆嚢・胆管・肝管中の結石で、赤血球
新生促進・鎮静・鎮痙・強心・血圧上昇・血圧下降・解
熱・利胆等の目的に用いられ、日局11に収載されてい
る。
■ Bezoar Bovis, O
riental Bezoar. Stones in the gallbladder, bile duct, and hepatic duct of bovine animals, yellow cattle (cows), and water buffaloes.It is used for the purposes of promoting erythropoiesis, sedation, antispasmodic, cardiotonic, increasing blood pressure, lowering blood pressure, antipyretic, and choleretic. It is featured on Japan Bureau 11.

【0014】■翠補:ウラボシ科の植物槲蕨(和名ハカ
マウラボシ)Drinaria  fortunei(
Kunze)J.Sm.,中華槲蕨Drynaria 
 baronii(Christ)Diels,石蓮姜
槲蕨Drynariapropinqua(Wall.
)J.Sm.,崖姜Pseudorynaria  c
oronans(Wall,)Ching、光亮密網蕨
Phymatodes  lucida(Roxb.)
Ching,及びシノブ科の植物骨砕補(和名シマキク
シノブ)Humata  Trifoliata  C
AV.,大葉骨砕補Davallia  orient
alis  C.Chr.(和名タイチュウシノブ)、
海州骨砕補(和名シノブ、タイワンシノブ)Daval
lia  mariesii  Moore等の蔓状の
根茎、水龍骨(和名アオネカズラ)Polypodiu
m  niponicum  Mett、の蔓状の根茎
も用いられる〔中薬大辞典−小学館、台湾植物名彙−天
然書社−台北市1982〕が、上記骨砕補・大葉骨砕補
・海州骨砕補・を骨砕補科とし和名ミヤマシノブ・シマ
シノブ・アツバシノブ・アリサンシノブ・コウトウシノ
ブ・キクシノブ・熱帯陰石蕨・アリサンオウレンシダを
列挙する書物〔台湾植物名彙−前掲〕もあり、鱗片状の
外皮を除いて使用され、腎を補い・血を活かす、止血す
る効能等があるとされている。
■ Drinaria fortunei: Drinaria fortunei (Japanese name: Hakamauraboshi)
Kunze) J. Sm. , Chinese Drynaria
Baronii (Christ) Diels, Drynaria propinqua (Wall.
)J. Sm. , Pseudorynaria c
oronans (Wall,) Ching, Phymatodes lucida (Roxb.)
Ching, and Humata Trifoliata C
A.V. , Davallia orient
alis C. Chr. (Japanese name Taichuushinobu),
Daval (Japanese name Shinobu, Taiwanese Shinobu)
Vine-like rhizomes such as lia mariesii Moore, Polypodiu (Japanese name: Aonekazura)
The vine-shaped rhizomes of M. niponicum Mett are also used [Encyclopedia of Traditional Chinese Medicine - Shogakukan, Taiwanese Botanical Dictionary - Tennen Shosha - Taipei City, 1982]. There is also a book [Taiwanese Botanical Nomenclature - supra] that lists the Japanese names Miyamashinobu, Shimashinobu, Atsubashinobu, Alisanshinobu, Koutoshinobu, Kikushinobu, Tropical staghorn bracken, and Alisan auren fern, which has a scaly outer skin. It is said to have the effect of replenishing the kidneys, activating blood, and stopping bleeding.

【0015】■含風草:キク科植物シロバナセンダング
サ(Bidens  pilosaL.var.min
or(Bl.)Sherff)の通常は全草を用いるが
、黄色の花を付けるものは効果が弱いが使用でき、ロッ
カクソウ(ホソバセンダングサBidens  par
viflora  Willd,鹿角草、刺針草とも)
、キンサンキンバン(金盞銀盤)〔コセンダングサBi
dens  pilosa或はセンダングサBinde
ns  biternata(Lour.)Merr.
et  Sherff〕も用いられ〔中薬大辞典−小学
館、原色牧野和漢薬草大図鑑−北隆館〕、鎮痛・利尿・
解毒・消炎等に使用されるが、本発明においてはその新
芽、若葉のみを使用すると良い。。
■Bidens pilosa L.var.min: Asteraceae plant Bidens pilosa L.var.min
Or (Bl.) Sherff), the whole plant is usually used, but those with yellow flowers can be used although the effect is weak,
viflora Will, also known as staghorn grass and prickly grass)
, Kinsan Kinbang (Kinshi Ginban)
dens pilosa or Binde
ns biternata (Lour.) Merr.
et Sherff] is also used [Encyclopedia of Chinese Medicine - Shogakukan, Primary Color Makino Encyclopedia of Japanese and Chinese Herbs - Hokuryukan], analgesic, diuretic,
It is used for detoxification and anti-inflammatory purposes, but in the present invention, it is preferable to use only its new shoots and young leaves. .

【0016】先ず、ブクリョウ(茯苓)をモウジュン(
毛筍)の抽出液を以って処理することを見出した、即ち
発明者の使用する薬剤による治療、或は自然治癒を伴う
胃癌・子宮癌・大腸癌・その他の癌の消失例につき、そ
の患者の食生活を詳細に調査したところ、当該患者らは
筍のス−プを常用し、而も筍を食するに当たって茹汁を
捨てることなく常用していることを見出したことに起因
する。
[0016] First, let's talk about Bukryo (Bukryo).
We have discovered cases where gastric cancer, uterine cancer, colorectal cancer, and other cancers disappeared by treatment with the drug used by the inventor or by natural recovery. After a detailed investigation of the patients' eating habits, it was discovered that these patients regularly consumed bamboo shoot soup, and that they regularly consumed bamboo shoots without throwing away the broth.

【0017】広く漢方に用いられるブクリョウ(茯苓)
は通常陰干しして冷暗所に保存し、亀裂を生じたり粘性
を失ったり乾燥し過ぎたりしないよう注意しなければな
らないものとされ、モウジュン(毛筍)の茹汁をこれに
配して熟成させる工程は、モウジュンの茹汁の存在によ
りブクリョウの自己消化に際してその成分変化が修飾さ
れることも考えられるが、むしろブクリョウ(茯苓)の
酵素の作用によりモウジュン(毛筍)の茹汁中の有効成
分、特に制癌・抗癌成分とその作用が増強されるもので
はないかと思われる。
[0017] Bukryo (Bukryo) widely used in Chinese medicine
The bamboo shoots are usually dried in the shade and stored in a cool, dark place, and care must be taken to prevent them from cracking, losing viscosity, or becoming too dry. Although it is possible that the presence of the boiled juice of Mōjung modifies the change in its components during autolysis of Bukryō, the active ingredients in the boiled water of Mōjung (hairy bamboo shoot) may be modified by the action of the enzyme of Bukryō In particular, anticancer/anticancer ingredients and their effects are thought to be enhanced.

【0018】その結果細胞膜を浄化し免疫系の補体を強
化し、本発明の組成物は一段とその効用を増大し、癌に
関しては白血病・子宮癌・ポリ−プ・乳癌等に著効例を
見、骨盤転移を起こした乳癌さえ全快して骨組織を新生
した例がある。
As a result, the composition of the present invention purifies cell membranes and strengthens the complement of the immune system, further increasing its efficacy, and has shown remarkable effects on leukemia, uterine cancer, polyp, breast cancer, etc. In fact, there are cases where even breast cancer that had metastasized to the pelvis was completely cured and new bone tissue was generated.

【0019】ビンロウジ(檳榔子)とダイオウ(大黄)
をズイホウ(翠補)と共に(或は別に抽出して熱いうち
に混合しても良い)水で加熱抽出する工程でも大量の原
料を処理する間相互の成分に対し相互に酵素作用の働く
ことが期待されるし、加熱による酵素の失活と共に相互
反応は化学反応に移行して複雑な成分構成をもたらすも
のと考えられ、これらは癌や腫瘍の毒素の排出を促し、
癌細胞の分裂を抑え骨髄芽を正常に働かせる作用を発揮
する。又痛みを的確に抑制する。
[0019] Areca nut and rhubarb
Even in the process of heating and extracting with water together with Zuihou (or you can extract it separately and mix it while it is hot), the enzyme action may work on each other's components while processing a large amount of raw materials. It is expected that as the enzymes are deactivated by heating, the mutual reactions will shift to chemical reactions and result in a complex composition of components, which will promote the excretion of cancer and tumor toxins,
It suppresses the division of cancer cells and promotes the normal functioning of bone marrow buds. It also suppresses pain accurately.

【0020】更に本発明ではガンフウソウ(含風草)を
配することにより、細胞の呼吸を促し酸素の供給を高め
、末期癌さえもその痛みをやわらげることに成功した。
Furthermore, according to the present invention, by distributing Chillinga japonica, we have been able to promote cell respiration and increase the supply of oxygen, thereby successfully alleviating the pain of even terminal cancer patients.

【0021】以下実施例により具体的に説明する、実施
例1:ブクリョウ(茯苓)40kgを細切しこれにモウ
ジュン(毛筍)20kgを水100lで2時間茹でた液
を加えて約37℃で丸一昼夜熟成し、天日で蒸発させ乾
燥後粉末化したものをAとし、ビンロウジ(檳榔子)2
5kg、ダイオウ(大黄)5kg、及びズイホウ(翠補
)5kgを刻んでこれに50lの水を加えて2時間煎じ
た液を約半分に濃縮しておき、一方カッセキ(滑石)1
5kg(予め金網上でゆっくりと焙焼したのち粉末とし
ておく)にその濾液を加えてどろどろの液となったもの
をBとし、BをAに少しずつ加えては天日乾燥をするこ
とを繰り返して粉末としたものをCとし、ガンフウソウ
(含風草)の新芽10kgを破砕してCに混合しては乾
燥するという操作を繰り返して乾燥粉末としたものをD
とし、ゴオウ(牛黄)粉末10kgを熱湯200lに溶
かしたものを更にDに吸収させて乾燥するという操作を
繰返し、全体を均一な粉末として目的の医薬品組成物5
0kgを得た、このものの一般分析値は次のとおりであ
る。
[0021] This will be explained in more detail with reference to the following examples. Example 1: 40 kg of Bukryo was cut into small pieces, and a liquid obtained by boiling 20 kg of Moujun (hairy bamboo shoots) in 100 liters of water for 2 hours was added thereto, and the mixture was heated at about 37°C. The product that is aged for a whole day and night, evaporated in the sun, dried and powdered is called A, and betel nut 2
5 kg of rhubarb, 5 kg of rhubarb, and 5 kg of zuiho were chopped and boiled in 50 liters of water for 2 hours.The liquid was concentrated to about half, while 1 kg of talc
The filtrate was added to 5 kg (roasted slowly on a wire mesh beforehand and then turned into powder), and the thick liquid became B, and B was added little by little to A and dried in the sun repeatedly. C was made into a powder, and D was made into a dry powder by repeating the process of crushing 10 kg of new shoots of Ganfuusou (wind-containing grass), mixing it with C, and drying it.
Then, repeat the operation of dissolving 10 kg of gouhou powder in 200 liters of boiling water, absorbing it in D, and drying it, and make the whole into a uniform powder to obtain the desired pharmaceutical composition 5.
0 kg was obtained, and the general analysis values of this product are as follows.

【0022】   水  分      蛋白質      脂  質
      繊  維      灰  分     
 糖  質  1.9%    1.0%    0.
3%    2.8%    83.3%  10.7
[0022] Moisture Protein Lipid Fiber Ash
Carbohydrate 1.9% 1.0% 0.
3% 2.8% 83.3% 10.7
%

【0023】実施例2:ブクリョウ(茯苓)50kg
を細かく刻み、これにモウジュン(毛筍)25kgを水
125lで2時間茹でた液を加えて約37℃で丸一昼夜
熟成し、天日で蒸発させ乾燥後粉末化し、一方ビンロウ
ジ(檳榔子)31kg、ダイオウ(大黄)6kg、及び
ズイホウ(翠補)6kgを刻んでこれに水62lを加え
て2時間煎じた液を約半分に濃縮しておき、金網上でゆ
っくりと焙焼し粉末としたカッセキ(滑石)19kgに
その濾液を加えて天日乾燥し、両粉末を混合し、ガンフ
ウソウの新芽13kgの磨砕物を混合しては乾燥すると
いう操作を繰返して乾燥粉末としたものに、熱湯150
lに溶かした粉末ゴオウ(牛黄)8kgを吸収させては
乾燥する操作を繰返し、全体を均一な乾燥粉末として8
2kgの目的医薬品組成物を得た、このものの一般分析
値は次のとおりであった。
Example 2: 50 kg of Bukryo
Finely chop 25 kg of betel nut, boil it in 125 liters of water for 2 hours, add the liquid, age at about 37°C for a whole day and night, evaporate it in the sun, dry it, and turn it into powder. Meanwhile, 31 kg of betel nut , 6 kg of rhubarb, and 6 kg of zuiho were chopped, 62 liters of water was added to them, and the mixture was decocted for 2 hours. The liquid was concentrated to about half, and the mixture was slowly roasted on a wire mesh to make powdered kasseki. Add the filtrate to 19 kg of talc, dry in the sun, mix both powders, mix with 13 kg of ground buds of Ganfuusou, and dry. Repeat this process to obtain a dry powder.
The process of absorbing 8 kg of powdered gourd (beef yellow) dissolved in 1 liter of water and drying it was repeated to make a uniform dry powder of 8 kg.
2 kg of the target pharmaceutical composition was obtained, and the general analytical values of this product were as follows.

【0024】   水  分      蛋白質      脂  質
      繊  維      灰  分     
 糖  質  5.0%    2.0%    0.
4%    4.5%    70.0%  18.1
[0024] Moisture Protein Lipid Fiber Ash
Carbohydrate 5.0% 2.0% 0.
4% 4.5% 70.0% 18.1
%

【0025】[0025]

【用法】得た医薬品組成物の投与開始の直後は免原反応
のため、発赤、湿疹、かゆみ等の副作用の見られること
があるが、これは体内毒素を排出する現象で改善の証拠
と見ることができ、又用法用量は症状により1回1ない
し4g、通常3gを内服、初期は1日3ないし4回から
経過を見ながらだんだん減らして1日1回にして体質改
善の維持効果をもたらすようにする。
[Usage] Immediately after starting administration of the obtained pharmaceutical composition, side effects such as redness, eczema, and itching may be observed due to the immunogenic reaction, but this is considered to be a phenomenon of expelling toxins from the body and evidence of improvement. The dosage is 1 to 4 g at a time depending on the symptoms, usually 3 g is taken orally at first, 3 to 4 times a day, and then gradually reduced while monitoring the progress to once a day to maintain the effect of improving the constitution. do it like this.

【0026】尚本発明の組成物を長期連用した人ではレ
ントゲン写真で骨の輪郭がきれいになることが認められ
、骨の新陳代謝が促進されて骨の再生が活発になること
が裏付けられ、また爪や角質化した足の裏の皮膚が瑞々
しく変わってくることも認められている。
[0026] In people who used the composition of the present invention for a long period of time, it was observed that the contours of the bones became clearer in X-ray photographs, supporting that bone metabolism was promoted and bone regeneration was activated. It has also been observed that the skin on the soles of the feet, which has become keratinized, becomes fresher and fresher.

【0027】試験例1:邱○○、60歳女、慢性肝炎で
水腫がひどかったが、実施例1で得た組成物12g/日
を4ヵ月投与したところ全快、その後健康状態良好であ
る。
Test Example 1: Chiu○○, a 60-year-old female, had severe edema due to chronic hepatitis, but after administering 12 g/day of the composition obtained in Example 1 for 4 months, she made a complete recovery and has been in good health since then.

【0028】試験例2:王○○、36歳男、B型肝炎、
実施例2で得た組成物8g/日を投与したところ6ヵ月
後全快、その後健康状態良好である。
Test Example 2: King XXX, 36-year-old male, hepatitis B,
When 8 g/day of the composition obtained in Example 2 was administered, the patient made a complete recovery 6 months later and has been in good health since then.

【0029】試験例3:呂○○、23歳男、慢性肝炎、
胃腸虚弱、頚部強直、実施例1で得た組成物8g/日を
投与したところ4ヵ月で全快、その後健康状態良好であ
る。
Test Example 3: Lu○○, 23-year-old male, chronic hepatitis,
The patient suffered from gastrointestinal weakness and neck stiffness. When 8 g/day of the composition obtained in Example 1 was administered, the patient completely recovered in 4 months and has been in good health since then.

【0030】試験例4:蔡○○、30歳男、他の医院で
肺癌と診断され、X線で肺部黒点散在、実施例2で得た
組成物12g/日、3ヵ月後から6g/日、計5ヵ月間
投与したところ全快、その後健康状態良好である。
Test Example 4: Cai○○, 30-year-old male, diagnosed with lung cancer at another hospital, X-rays showed scattered black spots in the lungs, 12 g/day of the composition obtained in Example 2, 6 g/day from 3 months later. After a total of 5 months of administration, the patient made a complete recovery and has been in good health ever since.

【0031】試験例5:○松○智、65歳男、肺炎を契
機に免疫不全・白血球減少が見出され、骨髄腫と診断さ
れ、当時白血球数は1700まで低下していた、内科的
治療を受けながら実施例1で得た組成物2gX3/日を
投与したところ10ヵ月で白血球数は5300程度にま
で回復し副作用と思われる症状は見られなかった。
Test Example 5: Satoshi Matsu, a 65-year-old man, was diagnosed with myeloma due to immunodeficiency and leukopenia caused by pneumonia, and his white blood cell count had dropped to 1700 at the time.He underwent medical treatment. When the patient received 2g x 3/day of the composition obtained in Example 1 while undergoing treatment, the white blood cell count recovered to about 5,300 in 10 months, and no symptoms that appeared to be side effects were observed.

【0032】試験例6:○木○子、28歳女、ぎっくり
腰を契機に体調の変化を来たし、生理痛、生理不順、貧
血、腰痛、自律神経失調等で転院を重ねたが捗々しく回
復しなく、内科受診を継続させながら実施例2で得た組
成物2gX2/日を投与したところ5ヵ月で軽度の生理
痛を残すのみで愁訴は殆ど消退した。
Test Example 6: ○Ki○ko, 28-year-old female, suffered from changes in her physical condition due to a strained back, and was repeatedly transferred to hospitals due to menstrual pain, irregular menstruation, anemia, lower back pain, autonomic nerve imbalance, etc., but she made a steady recovery. Instead, the patient continued to see an internal medicine doctor while administering 2 g x 2/day of the composition obtained in Example 2. After 5 months, the patient's complaints had almost disappeared with only mild menstrual pain remaining.

【0033】試験例7:○森○子、72歳女、手や腕の
紅斑、手足の関節痛、右腕挙手不能、歩行困難で膠原病
と診断されていた、実施例1で得た組成物2gX1/日
を3ヵ月投与したが改善が認められなかったので、同組
成物2gに牛黄0.1gを強化して1日3回服用させた
ところ4ヵ月で紅斑も関節痛も消退し、1年後には杖な
しで歩行が可能となった。
Test Example 7: Mori, 72-year-old female, diagnosed with collagen disease due to erythema on hands and arms, joint pain in hands and feet, inability to raise right arm, and difficulty walking. Composition obtained in Example 1. 2g x 1/day was administered for 3 months, but no improvement was observed, so 2g of the same composition was enriched with 0.1g of ox yolk and administered three times a day. Erythema and arthralgia disappeared within 4 months. A year later, he was able to walk without a cane.

【0034】試験例8:○田○造、54歳男、右手指関
節腫脹からリュウマチ症状発症、リュウマチ抗体陽性、
関節痛、両腕挙手困難進行、1年後には全身関節強直、
腫脹、歩行困難となり、発病前92kg有った体重をこ
の間に節制により70kgに減量した、ステロイド剤を
避けて入院加療の傍ら実施例2で得た組成物2gX4/
日を空腹時に投与したところ1週間後には黒色便を排出
、2週間後には関節の腫脹、疼痛の一時的増悪が見られ
たが次第に改善に転じ、120あった血沈値は3ヵ月で
70、9ヵ月で30まで低下し、歩行機能も回復、その
他の諸症状や各種臨床検査値も著名に改善された。
Test Example 8: ○da ○zo, 54-year-old male, developed rheumatic symptoms due to swelling of right finger joints, positive for rheumatoid antibodies.
Arthralgia, progressive difficulty in raising both arms, and 1 year later, whole body joint stiffness.
Due to swelling and difficulty walking, I reduced my weight from 92 kg before the onset of the disease to 70 kg through abstinence.While avoiding steroids and receiving treatment in the hospital, I received 2 g of the composition obtained in Example 2 x 4/
When the drug was administered on an empty stomach, 1 week later, black stool was excreted, and 2 weeks later, swelling of the joints and temporary exacerbation of pain were observed, but the symptoms gradually improved, and the blood sedimentation level, which was 120, decreased to 70 within 3 months. Within nine months, the temperature had dropped to 30, and walking function had recovered, and other symptoms and various clinical test values had also significantly improved.

【0035】試験例9:○東○子、47歳女、乳癌摘出
の1年余り後、骨盤への転移により座骨神経痛様の症状
を呈し歩行困難となった、実施例1で得た組成物2gX
3/日を投与したところ1ヵ月でやや改善が認められ、
4ヵ月で歩行可能となり、疼痛その他の諸症状は全て消
失した、この患者は転移癌発見後は本剤の服用以外の治
療を受けなかった。
Test Example 9: Azumako, a 47-year-old female, who developed sciatica-like symptoms due to metastasis to the pelvis and had difficulty walking more than one year after breast cancer was removed. The composition obtained in Example 1. 2gX
After administering 3/day, slight improvement was observed after 1 month.
The patient was able to walk within 4 months, and all pain and other symptoms disappeared. After the discovery of metastatic cancer, this patient received no treatment other than taking this drug.

【0036】試験例10:○出○子、13歳女、白血球
14万、赤血球200万を示していた白血病、抗癌剤投
与による脱毛が酷い状態であった、入院治療のまま実施
例2で得た組成物1.5gX3/日を空腹時に投与した
ところ3ヵ月目から赤血球の増加、6ヵ月目からは白血
球の減少と毛髪の回復が認められ、2年後には正常値を
回復した、予後3年間2gX1/日を継続投与し観察し
たが健康状態が安定したので投薬を打ち切った。
Test Example 10: Ideko, a 13-year-old female, had leukemia with a white blood cell count of 140,000 and a red blood cell count of 2,000,000, and had severe hair loss due to administration of anticancer drugs. Obtained in Example 2 while undergoing hospital treatment. When 1.5g x 3/day of the composition was administered on an empty stomach, an increase in red blood cells was observed from the 3rd month, a decrease in white blood cells and recovery of hair from the 6th month, and the values returned to normal after 2 years. Prognosis: 3 years. The patient was continuously administered 2 g x 1/day and observed, but as his health condition stabilized, the medication was discontinued.

【0037】試験例11:○福○子、64歳女、摘出不
能の末期子宮癌、赤血球白血球とも著しく低下、抗癌剤
により無毛、自宅で死期を待つのみの状態であったが、
実施例1で得た組成物2gX4/日を投与したところ徐
々に改善が認められ、疼痛は軽減し局部の出血も減少し
た。1年後2gX3/日、2年後2gX2/日、3年後
から維持量として2gX1/日に減量しているが、赤血
球白血球とも正常値を回復している、この間他の治療を
受けなかった。
Test Example 11: Fukuko, a 64-year-old female, had unremovable terminal uterine cancer. Her red and white blood cells were significantly reduced. Due to anticancer drugs, she was hairless and was waiting at home to die.
When 2 g of the composition obtained in Example 1 was administered 4 times a day, gradual improvement was observed, with pain being reduced and local bleeding reduced. The dose was reduced to 2 g x 3/day after 1 year, 2 g x 2/day after 2 years, and 2 g x 1/day as a maintenance dose after 3 years, but both red and white blood cell values have returned to normal. During this time, no other treatment was received. .

【0038】試験例12:○塚○夫、56歳男、超音波
診断で直径約4cmの肝臓癌を発見、実施例2で得た組
成物2gX4/日を空腹時に投与したところ8ヵ月で肝
臓癌の影像は消失した、この間他の薬剤の投与は受けな
かった。
Test Example 12: Mr. Tsuka, 56 years old, liver cancer with a diameter of about 4 cm was discovered by ultrasonic diagnosis. When 2 g of the composition obtained in Example 2 was administered 4 times a day on an empty stomach, liver cancer was detected in 8 months. The image disappeared, and no other drugs were administered during this time.

【0039】試験例13:○泉○一、63歳男、右膝関
節に漿液が溜り正座や蹲踞が不能で整形外科を受診、水
を抜き湿布するのみの治療であったが、2ヵ月間に20
乃至27mlの水を4回抜いても軽快せず、歩行には階
段を忌避する程度の痛みがあった、この治療を止めて実
施例1で得た組成物1gX2/日を投与したところ1ヵ
月で痛みは殆ど消失し漿液も溜らず、正座蹲踞も可能と
なった。
Test Example 13: Izumi○ichi, a 63-year-old man, was visited by an orthopedic clinic because he was unable to sit upright or crouch due to serous fluid buildup in his right knee joint.The only treatment he received was to drain the water and apply a compress, but within 2 months 20
Even after draining 27 ml of water four times, the pain did not improve and the pain was so bad that she had to avoid stairs when walking.This treatment was stopped and 1 g of the composition obtained in Example 1 was administered per day for one month. The pain almost disappeared, the serous fluid did not accumulate, and I was able to sit upright and crouch.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】  ブクリョウ(茯苓)にモウジュン(毛
筍)の抽出液を加えて熟成して乾燥し、カッセキ(滑石
)にビンロウジ(檳榔子)・ダイオウ(大黄)・ズイホ
ウ(翠補)の抽出液を加え混合して乾燥し、これらの乾
燥粉末に、破砕した生のガンフウソウ(含風草)及び熱
湯に溶かしたゴオウ(牛黄)を逐次反復吸収乾燥させ、
全体を均一な乾燥粉末とすることを特徴とする医薬品組
成物。
Claim 1: Add extract of Moujun (hairy bamboo shoots) to Bukuryo, mature and dry, and extract betel nut, rhubarb, and zuihou to kasseki (talc). Add the liquid, mix and dry, and then repeatedly absorb and dry crushed raw Ganfuusou (wind-containing grass) and Gooh (ox yellow) dissolved in boiling water to these dry powders,
A pharmaceutical composition characterized in that the entire composition is a uniform dry powder.
【請求項2】  カッセキ(滑石)が焙焼したものであ
ることを特徴とする請求項1記載の医薬品組成物。
2. The pharmaceutical composition according to claim 1, wherein the talc is roasted.
【請求項3】  ゴオウ(牛黄)は予め徐々に加熱し滲
出した油分を充分取り除いた後粉末としたものであるこ
とを特徴とする請求項1記載の医薬品組成物。
3. The pharmaceutical composition according to claim 1, wherein the Gouou (Cow yellow) is powdered after being gradually heated in advance to sufficiently remove exuded oil.
【請求項4】  ガンフウソウ(含風草)は新芽である
ことを特徴とする請求項1記載の医薬品組成物。
4. The pharmaceutical composition according to claim 1, wherein the herbaceous plant is a new sprout.
JP3012849A 1991-01-09 1991-01-09 Manufacturing method of immunity strengthening and constitution improving agent Expired - Lifetime JPH0761953B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3012849A JPH0761953B2 (en) 1991-01-09 1991-01-09 Manufacturing method of immunity strengthening and constitution improving agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3012849A JPH0761953B2 (en) 1991-01-09 1991-01-09 Manufacturing method of immunity strengthening and constitution improving agent

Publications (2)

Publication Number Publication Date
JPH04243834A true JPH04243834A (en) 1992-08-31
JPH0761953B2 JPH0761953B2 (en) 1995-07-05

Family

ID=11816845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3012849A Expired - Lifetime JPH0761953B2 (en) 1991-01-09 1991-01-09 Manufacturing method of immunity strengthening and constitution improving agent

Country Status (1)

Country Link
JP (1) JPH0761953B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003073315A (en) * 2001-09-04 2003-03-12 Musashino Meneki Kenkyusho:Kk Anti-inflammatory vegetable ingredients
EP1295592A1 (en) * 2001-09-20 2003-03-26 Kao Corporation Hair growth inhibitor and depilation accelerator
JP2005255668A (en) * 2005-01-07 2005-09-22 Musashino Meneki Kenkyusho:Kk Cosmetic
JP2006182678A (en) * 2004-12-27 2006-07-13 Daicho Kikaku:Kk Constitution-improving agent
JP2007016053A (en) * 2006-10-23 2007-01-25 Pola Chem Ind Inc Antineoplastic agent
CN104069199A (en) * 2014-07-30 2014-10-01 董宝珍 Geranium wilfordii maxim traditional Chinese medicine decoction for treating rheumatoid arthritis and preparation method
CN108526216A (en) * 2018-04-24 2018-09-14 四川农业大学 A method of improving bidens pilosa cadmium pollution repair ability

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63255235A (en) * 1987-04-13 1988-10-21 Kozo Niwa Low-molecular vegetable antimalignant tumor agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63255235A (en) * 1987-04-13 1988-10-21 Kozo Niwa Low-molecular vegetable antimalignant tumor agent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003073315A (en) * 2001-09-04 2003-03-12 Musashino Meneki Kenkyusho:Kk Anti-inflammatory vegetable ingredients
EP1295592A1 (en) * 2001-09-20 2003-03-26 Kao Corporation Hair growth inhibitor and depilation accelerator
US7488499B2 (en) * 2001-09-20 2009-02-10 Kao Corporation Herbal hair growth inhibitor and depilation accelerator
JP2006182678A (en) * 2004-12-27 2006-07-13 Daicho Kikaku:Kk Constitution-improving agent
JP2005255668A (en) * 2005-01-07 2005-09-22 Musashino Meneki Kenkyusho:Kk Cosmetic
JP4518959B2 (en) * 2005-01-07 2010-08-04 株式会社武蔵野免疫研究所 Cosmetics
JP2007016053A (en) * 2006-10-23 2007-01-25 Pola Chem Ind Inc Antineoplastic agent
CN104069199A (en) * 2014-07-30 2014-10-01 董宝珍 Geranium wilfordii maxim traditional Chinese medicine decoction for treating rheumatoid arthritis and preparation method
CN108526216A (en) * 2018-04-24 2018-09-14 四川农业大学 A method of improving bidens pilosa cadmium pollution repair ability

Also Published As

Publication number Publication date
JPH0761953B2 (en) 1995-07-05

Similar Documents

Publication Publication Date Title
JPH04243834A (en) Pharmaceutical composition
CN106039109A (en) Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis
CN107115493A (en) It is a kind of to treat Chinese medicine composition of fracture and its production and use
CN105999058B (en) Bidens bipinnata lipid-lowering tablet
CN101647985B (en) Medicament composition for treating psoriasis
CN104001131A (en) Oral traditional Chinese medicine for preventing and treating stress ulcers
CN104547251B (en) A kind of navel patch and preparation method for treating chordapsus
CN103550744B (en) A kind of pure Chinese medicinal preparation for oral ulcer
CN103212030B (en) Traditional Chinese medicine for treating liver depression type hyperplasia of mammary glands and preparation method thereof
CN108578473A (en) A kind of drug and preparation method thereof for treating stomachache
CN104758835B (en) A kind of Chinese medicine being used for the treatment of cerebral infarction disease
CN103933154A (en) Traditional Chinese medicine composition for treating gout disease and preparation method thereof
CN103877484A (en) Traditional Chinese medicine oral liquid for treating oral liquid
CN107007697A (en) One kind treats pelvic infecton or prostatitic Chinese medicine composition and its preparation
CN101167915B (en) Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method
CN101376017A (en) Chinese medicine for treating constipation and preparation method thereof
CN105998256A (en) Medicament for treating urinary calculus and preparation method of medicament
CN105412724A (en) Traditional Chinese medicine composition for treating syphilis and preparation method thereof
CN105597004A (en) Traditional Chinese medicine combination for treating cancer
CN1064536C (en) Full-divergence promoting medicine for curing fourth-phase carcinoma of stomach and its processing method
CN105031364A (en) Preparation for preventing and treating toothache due to wind-fire evil and preparation method of preparation
CN104825980A (en) Traditional Chinese medicine preparation for treating diarrhea
CN1180826C (en) Medicament for promoting exhaustion from anus and its preparation method
CN103933514B (en) A kind of medicine of quick row's eliminating pathogen in the liver ascites
CN111905041A (en) Traditional Chinese medicine composition for treating hyperlipidemia by steam therapy and preparation method thereof